Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of Tongzu He Ya Ri Xian Bai Er tablets for constipation (abnormal bile humor type)
CTR20244963Phase 2Active
- Sponsor
- 新疆银朵兰药业股份有限公司，北京中医药大学/ 新疆银朵兰药业股份有限公司
- Start
- Mar 2025
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in constipation comparing Tongzu He Ya Ri Xian Bai Er tablets with Placebo comparator (2 arms). Primary endpoints: Complete spontaneous bowel movement responder rate at Day 7 and Complete spontaneous bowel movement responder rate at Day 14. Started Mar 2025; status: active.
02
Drugs
Tongzu He Ya Ri Xian Bai Er tablets
03
Conditions
constipation
Beyond the preview
Go deeper on CTR20244963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244963.